Chromosomal Abnormalities Affect the Surgical Outcome in Infants with Hypoplastic Left Heart Syndrome: A Large Cohort

Dala Zakaria1, Xinyu Tang2, Rupal Bhakta3

  • 1Pediatric Cardiology, Arkansas Children's Hospital, University of Arkansas for Medical Sciences, Little Rock, AR, USA. dzakaria@uams.edu.

Pediatric Cardiology
|September 19, 2017
PubMed

Insights

Genetic abnormalities affect 5% of hypoplastic left heart syndrome (HLHS) infants, increasing morbidity and mortality. Early genetic testing and counseling are crucial for these complex pediatric cardiac cases.

Area of Science:

  • Pediatric Cardiology
  • Clinical Genetics
  • Congenital Heart Disease Research

Background:

  • Hypoplastic left heart syndrome (HLHS) is a complex congenital heart defect.
  • Genetic abnormalities are frequently associated with HLHS, potentially impacting patient outcomes.
  • Understanding the incidence and impact of these genetic conditions is vital for clinical management.

Purpose of the Study:

  • To determine the incidence of genetic abnormalities in infants diagnosed with HLHS.
  • To evaluate the short-term outcomes of HLHS infants with and without genetic abnormalities during their initial hospitalization.
  • To identify predictors of mortality in HLHS infants with genetic abnormalities undergoing cardiac surgery.

Main Methods:

  • Retrospective analysis of the Pediatric Heath Information System database (2004-2013).
  • Inclusion criteria: infants with HLHS undergoing Stage I Norwood, Hybrid, or heart transplant during their first hospitalization.
  • Comparison of clinical data between infants with and without genetic abnormalities, analysis of common chromosomal abnormalities, and survivor vs. non-survivor outcomes; multivariable mortality analysis performed.

Main Results:

  • A total of 5721 HLHS infants were identified; 282 (5%) had associated genetic abnormalities.
  • Most common chromosomal abnormalities included Turner (25%), DiGeorge (22%), and Down syndromes (12.7%).
  • Infants with genetic abnormalities experienced longer hospital stays, higher morbidity, and mortality compared to those without; key mortality predictors included lower gestational age, vasopressor use, dialysis, CPR, necrotizing enterocolitis, and septicemia.

Conclusions:

  • The presence of any genetic abnormality in infants with HLHS undergoing cardiac surgery is linked to increased mortality and morbidity.
  • Despite an increase in operations for infants with genetic abnormalities, mortality rates did not significantly rise over the study period.
  • Recommendations include timely genetic testing, comprehensive family counseling, and meticulous preoperative case selection for operative interventions in HLHS patients with genetic conditions.